Specifically, patients with mutated CLL exhibited a significant elevation in IL‐6, MIP‐1α, and MIP‐1β but a reduction in TARC levels compared to their unmutated counterparts (Fig. 6H–K). Here, IL6 is linked to B-cell chronic lymphocytic leukemia.